As part of his guilty plea, Dr. Abbott admitted to knowingly distributing hydrocodone on 44 occasions without a legitimate medical purpose and outside the standard of professional practice.
Dr. Abbott distributed the Schedule II controlled substance to four patients between April 2013 and February 2019, according to his guilty plea in the Middle District of Tennessee.
Dr. Abbott’s sentencing is scheduled for Aug. 31. Click here for more details on the case.
More articles on orthopedics:
Zimmer Biomet cervical disc surpasses 150,000 implants
Orthofix’s positive Q4 can’t eclipse $28M 2019 loss
SASpine partners with Dr. Stanley Jones, establishes new location
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
